Tag: BioNTech
ASCO News: BioNTech and Pfizer’s bispecifics, and Pazdur — Day 2
Adam Feuerstein/STAT Adam Feuerstein is a senior writer and biotech columnist, reporting on drug development, business, Wall Street,…
BioNTech Strengthens UK Ties with Investment of Up to $1.33 Billion
German biotech company BioNTech SE (NASDAQ:BNTX) recently announced its plans to strengthen its presence in the UK with…
Promising BioNTech data on triple negative breast cancer treatment
Researchers may have discovered a promising candidate for the next generation of immunotherapy drugs in the form of…